HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruiqiong Ye Selected Research

Ataxia Telangiectasia Mutated Proteins

10/2019Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
1/2014Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.
3/2010Protein phosphatase 6 interacts with the DNA-dependent protein kinase catalytic subunit and dephosphorylates gamma-H2AX.
11/2004Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A.
3/2004The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruiqiong Ye Research Topics

Disease

8Ataxia Telangiectasia (Louis Bar Syndrome)
06/2020 - 03/2004
4Neoplasms (Cancer)
11/2020 - 06/2012
2Lung Neoplasms (Lung Cancer)
06/2020 - 10/2019
1Adenocarcinoma of Lung
10/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2014
1Stomach Neoplasms (Stomach Cancer)
01/2014
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2012
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
08/2006
1Glioma (Gliomas)
03/2005
1Thrombosis (Thrombus)
07/2002

Drug/Important Bio-Agent (IBA)

5Ataxia Telangiectasia Mutated ProteinsIBA
10/2019 - 03/2004
5DNA (Deoxyribonucleic Acid)IBA
11/2011 - 03/2005
3Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2012
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2020 - 06/2012
3Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2019 - 06/2012
3olaparibIBA
10/2019 - 06/2012
3Phosphotransferases (Kinase)IBA
01/2014 - 03/2004
3Serine (L-Serine)FDA Link
03/2010 - 11/2004
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
03/2010 - 03/2005
1A-Form DNA (A-DNA)IBA
11/2020
1Long Noncoding RNAIBA
11/2020
1Messenger RNA (mRNA)IBA
10/2019
13- amino- 6- (4- (methylsulfonyl)phenyl)- N- phenylpyrazine- 2- carboxamideIBA
10/2019
1Pharmaceutical PreparationsIBA
10/2019
1talazoparibIBA
10/2019
12- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1Small Interfering RNA (siRNA)IBA
01/2014
1DNA-Activated Protein KinaseIBA
11/2011
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2011
1Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA
11/2011
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
11/2004
1Monoclonal AntibodiesIBA
07/2002
1FibrinIBA
07/2002

Therapy/Procedure

1Therapeutics
11/2020